Chief Business Development Officer
Paul Pay is the Chief Business Development Officer at Norgine. Paul has over 35 years’ experience in the pharmaceutical industry in a range of commercial roles. These have covered sales, marketing, market research, licensing, business development and general management. Paul joined Norgine in November 2002. Prior to that he worked for a number of companies covering Big Pharma (Wellcome, Fisons), “biotechs” (Xenova, Andaris) and a university spin-out (Aegis). He has worked in the UK and the USA.
sales, marketing, market research, licensing, business development and general management.